Indeed, OLZ monotherapy in SZ patients for two months also elevated plasma MIF levels, thereby contributing to insulin resistance, obesity, and hyperlipidemia [17]. This evidence concerns the gene MIF and obesity due to melanocortin 4 receptor deficiency.